Advanced training in endoscopy gastro-intestinal cancers
18 ESCO credits
01.03.2024 - 04.03.2024
Rotterdam, The Netherlands
COURSES AND SEMINARS
Description
Chairs: Massimo Conio, IT – Peter D. Siersema, NL
The last five years, gastrointestinal endoscopy has seen an impressive progress in diagnosing and treating premalignant and early malignancy but also palliating malignancy at a stage when cure is no longer possible. The aim of this advanced course is to provide an update by experts in the respective fields.
The advanced course is specifically addressed to junior specialists and each topic will be analyzed in a systematic and propaedeutic way, from basic to the most complex and difficult procedures. The advanced course will consist of a series of focused presentations, update lectures and video sessions. Presenters will be using case illustrative examples and high-quality video throughout the programme. In addition, live endoscopy cases will be demonstrated.
We aim to for high level interaction between the faculty and the participants throughout the course and clinical case discussions in groups will be scheduled each day where the participants’ clinical cases will be discussed. The importance of the multidisciplinary approach to gastrointestinal cancers will be highlighted.
Together with gastroenterologists, interventional radiologists, surgeons and oncologists, participants will be actively involved both in the presentations and in the discussions.
The key aim of the course is to illustrate that gastrointestinal endoscopy may offer its best potential particularly when it is part of a comprehensive clinical evaluation of the patient.
LEARNING OBJECTIVES
• Update on epidemiology of gastrointestinal cancers and precancerous conditions/lesions.
• Appraise the role of endoscopy in several scenarios.
• Discuss cancer genetics and the role of endoscopy.
• Update on endoscopic diagnostic approaches and endotherapy in a multidisciplinary perspective.
• Update on technological innovations.
• Discuss indications and limits of endoscopy and methods to acquire competency in endoscopy.
• Competency in endoscopy but also in clinical research: how to prepare a research protocol.
Information
TEACHING FORMAT
The advanced course offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines, which will be concluded in take-home messages.
Participants will deliver case presentations and discuss these with the chairs and the faculty.
Admitted participants will be requested to take part in the whole event. The advanced course will be entirely in English and fluency in English is necessary for admission.
THE ADVANCED COURSE:
• Is a 4-day residential, educational and practical event
• Presents full covering of premalignant lesions and malignancies of the gastrointestinal tract
• Is clinically and multi-disciplinary-oriented
• Includes an international faculty of top experts delivering lectures and holding interactions focusing on the management of esophageal, gastric, hepatobiliary, pancreatic and colon cancer
• Provides active interaction with other junior specialists from various countries and the experts
• Is located at a teaching university hospital
ACCREDITATION
Participants will be issued a certificate of attendance. An online evaluation questionnaire and learning assessment test will need to be completed in order to get the certificate that will be sent by email.
Application for CME recognition will be submitted to the Accreditation Council of Oncology in Europe (ACOE). The American Medical Association (AMA) and the Accreditation Council for Continuous Medical Education (ACCME) designate this type of educational activity for a maximum of 1 AMA PRA category 1 credits per hour of activity.
ESCO - The ESO College
Being selected to take part in this ESO activity gives participants eligibility to enrol in ESCO - the College of the European School of Oncology.
This event also enables ESCO students to earn ESCO credits and therefore access more ESCO benefits.
Full and active participation in the event earns participants 18 ESCO credits.
Visit www.ESCO.org for more information on how to join ESCO.
LANGUAGE
The advanced course will be held in English and translation will not be provided.
INSURANCE
The organizers bear no responsibility for untoward events in relation to the participation in the Conference. Participants are advised to take out their own personal and travel insurance coverage.
Application
APPLICATIONS DEADLINE 15 DECEMBER 2023
PARTICIPATION
Attendance is limited to 50 participants and admittance is by competitive application only.
Successful applicants are required to pay a fee of EUR 300, which covers:
- Access to the course and its educational resources
- Accommodation for 3 nights in Rotterdam
- Meals according to the programme
The fee does not cover travel costs, these should be organized and paid by the participant.
A discount of 100 EUR is given to participants who are already ESCO members.
The registration fee for this event is a small contribution towards the cost for organising it, therefore it will not be refunded if a participant withdraws or is unable to attend, for whatever reason.
IDEAL PROFILE OF THE ADVANCED COURSE CANDIDATE
• Young specialists (40 years or younger) in gastroenterology and endoscopy
• Interest in clinical research
• Fluency in English
HOW TO APPLY
Interested oncologists should apply online (at the top of this page) providing:
- Letter describing motivation for attending;
- Supporting letter from head of department or mentor;
- CV with list publications (if the list of publications is not provided, it will be assumed that no articles have been published)
- Clinical case (please, use this template)
ATTENDANCE TO THE ADVANCED COURSE IS BY APPLICATION ONLY.
Programme
1 March | ||
| 13:30 | Registration | |
| 14:30 | Welcome | |
| 14:45 | ESOPHAGUS – BARRETT’S ESOPHAGUS Part 1 | |
| 14:45 | Screening and Surveillance of Barrett’s esophagus Manon Spaander, NL | |
| 15:05 | Live Endoscopy | |
| 15:50 | When to perform esophageal resection or ablation in Barrett’s esophagus? de Jonge Peter Jan, NL | |
| 16:10 | Coffee break | |
| 16:35 | ESOPHAGUS – BARRETT’S ESOPHAGUS Part 2 | |
| 16:35 | Screening and Surveillance of squamous cell cancer Arjun Koch, NL | |
| 16:55 | Early esophageal cancer – EMR or ESD? Rehan Haidry, UK | |
| 17:15 | Discussion | |
| 17:30 | Clinical case presentation | |
| 18:30 | End of the day | |
2 March | ||
| 9:00 | ESOPHAGUS – ESOPHAGEAL CANCER | |
| 9:00 | Novel developments in endoscopic mucosal imaging de Jonge Peter Jan, NL | |
| 9:20 | Update lecture: Barrett’s esophagus – new development (role of artificial intelligence) Erik Schoon, NL | |
| 9:50 | Palliation of advanced esophageal cancer Peter Siersema, NL | |
| 10:10 | Discussion | |
| 10:25 | Clinical case presentation | |
| 11:10 | Coffee break | |
| 11:43 | ESOPHAGUS – POTPOURRI | |
| 11:35 | POEM: when and how Rehan Haidry, UK | |
| 11:55 | Zenker’s diverticulum: the endoscopic solution Arjun Koch, NL | |
| 12:15 | Endoscopic management of problematic strictures (hypopharynx…) Massimo Conio, IT | |
| 12:35 | Clinical case presentation | |
| 13:25 | Lunch | |
| 14:15 | STOMACH – (EARLY) GASTRIC TUMOR AND OTHER TUMORS - Part 1 | |
| 14:15 | Update lecture: Endoscopic and clinicopathological characteristics of early gastric cancer Judith Honing, NL | |
| 14:45 | Surveillance of atrophic gastritis, intestinal metaplasia Judith Honing, NL | |
| 15:05 | Diagnosis and endoscopic treatment of submucosal tumors | |
| 15:25 | Familial Gastric Cancer Judith Honing, NL | |
| 15:45 | Coffee break | |
| 16:10 | Clinical case presentation | |
| 17:10 | STOMACH – (EARLY) GASTRIC TUMOR AND OTHER TUMORS - Part 2 | |
| 17:10 | Diagnosis and endoscopic treatment of GIST | |
| 17:30 | Update lecture: Endoscopic treatment of gastric outlet obstruction Peter Siersema, NL | |
| 18:00 | Missing upper gastrointestinal cancer at endoscopy – How often and how to prevent? Nigel Trudgill, UK | |
| 18:30 | End of the day | |
3 March | ||
| 9:00 | PANCREATICOBILIARY CANCER | |
| 9:00 | Update lecture: The role of EUS-guided interventions in pancreaticobiliary malignancies | |
| 9:30 | Tips and tricks for a successful ERCP cannulation in pancreaticobiliary malignancies Massimiliano Mutignani, IT | |
| 9:50 | Management of hilar cholangiocarcinoma | |
| 10:10 | Update lecture: The multidisciplinary approach for pancreatic cancer and cholangiocarcinoma Massimiliano Mutignani, IT | |
| 10:20 | Discussion | |
| 10:35 | Clinical case presentation | |
| 11:30 | Coffee break | |
| 11:55 | GI BLEEDING | |
| 11:55 | Update lecture: Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants Franco Radaelli, IT | |
| 12:25 | New hemostatic therapies – Sprays, gels, clips, OTSCs | |
| 12:45 | SMALL BOWEL TUMORS | |
| 12:45 | Update lecture: Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel tumors Marco Pennazio, IT | |
| 14:15 | Update lecture: Endoscopic management of enteral tubes – Indications and management Edward Despott, UK | |
| 13:15 | Lunch | |
| 14:45 | COLON – POLYPS Part 1 | |
| 14:45 | Endoscopic and clinicopathological characteristics of premalignant colorectal lesions Helmut Neumann, DE | |
| 15:05 | Why is it important to differentiate between adenomatous and serrated polyps, or is it not? | |
| 15:25 | When to perform EMR and when ESD for in advancer colorectal neoplasia? Massimo Conio, IT | |
| 15:45 | Computer-assisted systems (CADe/CADx) for detection and characterization of colorectal neoplasia – hype of here to stay? Helmut Neumann, DE | |
| 16:05 | Discussion | |
| 16:20 | Coffee break | |
| 16:45 | COLON – POLYPS Part 2 | |
| 16:45 | Update lecture: Challenges in T1 colorectal cancer Leon Moons, NL | |
| 17:15 | Clinical case presentation | |
| 18:15 | End of the day | |
4 March | ||
| 9:00 | COLON – POLYPS Part 3 | |
| 9:00 | Risk assessment in familial and hereditary colorectal cancer Monique van Leerdam, NL | |
| 9:20 | Tips and tricks for performing polypectomy – hot snare, cold snare, underwater, etc. David Tate, BE | |
| 9:40 | How to treat recurrent of residual colorectal lesions? Leon Moons, NL | |
| 10:00 | Discussion | |
| 10:15 | Clinical case presentation | |
| 10:10 | GI BLEEDING | |
| 11:10 | Risk classification after colonoscopy and polypectomy: Which follow-up schedule is appropriate? | |
| 11:25 | Colonoscopic surveillance in inflammatory bowel disease Lauranne Derikx, NL | |
| 11:55 | How to treat (obstructing) colorectal cancer – Stent or surgery? Mario Morino, IT | |
| 12:15 | Discussion | |
| 10:45 | Coffee break | |
| 12:30 | Closing remarks and departures | |
Faculty
Massimo Conio, Santa Corona & San Paolo General Hospitals, Gastroenterology Dpt., Pietra Ligure, IT
Lauranne Derikx, Radboudumc, Gastroenterology And Hepatology Dept., Nijmegen, NL
Edward Despott, University College London, Endoscopy Dpt., London, UK
Rehan Haidry, Cleveland Clinic London, Consultant Gastroenterologist, London, UK
Judith Honing, Erasmus University Medical Center, Gastro-enterology Dpt., Rotterdam, NL
Arjun Koch, Erasmus University Medical Center, Gastrointestinal Cancers Dpt., Rotterdam, NL
Leon Moons, University Medical Center Utercht, Gastroenterology & Hepatology Dept., Utrecht, NL
Mario Morino, University of Turin, Dept.of Surgical Sciences, Section of Digestive and Minimal Invasive Surgery, Torino, IT
Massimiliano Mutignani, Niguarda Hospital, Surgical Department, Milan, IT
Helmut Neumann, University Medical Center Mainz, Interdisciplinary Endoscopy Center, Mainz, DE
Marco Pennazio, City of Health and Science University Hospital, Division of Gastroenterology, Torino, IT
de Jonge Peter Jan, Erasmus University Medical Center, Endoscopy Dpt., Rotterdam, NL
Franco Radaelli, Valduce Hospital, Gastro-enterology Dpt., Como, IT
Erik Schoon, Catharina Ziekenhuis, Therapeutic Endoscopy Dpt., Eindhoven, NL
Peter Siersema, Erasmus University Medical Center, Dept. of Gastroenterology and Hepatology, Rotterdam, NL
Manon Spaander, Erasmus Medical Center, Gastroenterology & Hepatology Dept., Rotterdam, NL
David Tate, University Hospital of Ghent, Endoscopy Dpt., Ghent, BE
Nigel Trudgill, NHS Sandwell and West Birmingham, Gastrointestinal cancer and therapeutic endoscopy Dpt., Birmingham, UK
Monique van Leerdam, The Netherlands Cancer Institute, Gastroenterologist and Clinical Epidemiologist, Amsterdam, NL